These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19250278)

  • 1. Translating transplantation tolerance in the clinic: where are we, where do we go?
    Goldman M; Wood K
    Clin Exp Immunol; 2009 May; 156(2):185-8. PubMed ID: 19250278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
    Dresske B; Haendschke F; Lenz P; Ungefroren H; Jenisch S; Exner B; El Mokhtari NE; Lu T; Zavazava N; Faendrich F
    Transplantation; 2006 Jun; 81(11):1549-57. PubMed ID: 16770244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in strategies for inducing central tolerance in organ allograft recipients.
    Guenther DA; Madsen JC
    Pediatr Transplant; 2005 Jun; 9(3):277-81. PubMed ID: 15910381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance after liver transplantation: Where are we?
    Feng S; Bucuvalas J
    Liver Transpl; 2017 Dec; 23(12):1601-1614. PubMed ID: 28834221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of 23 operational tolerant liver transplant recipients.
    Tryphonopoulos P; Ruiz P; Weppler D; Nishida S; Levi DM; Moon J; Tekin A; Velez M; Neuman DR; Island E; Selvaggi G; Tzakis AG
    Transplantation; 2010 Dec; 90(12):1556-61. PubMed ID: 21085060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimization of immunosuppression in adult liver transplantation: new strategies and tools.
    Londoño MC; López MC; Sánchez-Fueyo A
    Curr Opin Organ Transplant; 2010 Dec; 15(6):685-90. PubMed ID: 20885324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival.
    Tantisattamo E; Leventhal JR; Mathew JM; Gallon L
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):63-74. PubMed ID: 33186221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the identification of biomarkers of transplantation tolerance.
    Turka LA; Lechler RI
    Nat Rev Immunol; 2009 Jul; 9(7):521-6. PubMed ID: 19483711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia.
    Turka LA; Wood K; Bluestone JA
    Curr Opin Organ Transplant; 2010 Aug; 15(4):441-8. PubMed ID: 20631613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.
    Sarwal MM
    Clin Biochem; 2016 Mar; 49(4-5):404-10. PubMed ID: 26794635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 'biomarker signature' for tolerance in transplantation.
    Hernandez-Fuentes MP; Lechler RI
    Nat Rev Nephrol; 2010 Oct; 6(10):606-13. PubMed ID: 20717098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation?
    Pons JA; Revilla Nuin B; Ramírez P; Baroja Mazo A; Martínez Alarcón L; Robles R; Sánchez Bueno F; Rios A; Cascales Campos P; Parrilla P
    Transplant Proc; 2012; 44(6):1530-2. PubMed ID: 22841204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.
    Gallon L; Mathew JM; Bontha SV; Dumur CI; Dalal P; Nadimpalli L; Maluf DG; Shetty AA; Ildstad ST; Leventhal JR; Mas VR
    J Am Soc Nephrol; 2018 Feb; 29(2):423-433. PubMed ID: 29191961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
    Leventhal JR; Ildstad ST
    Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring the operationally tolerant liver allograft recipient.
    Castellaneta A; Thomson AW; Nayyar N; de Vera M; Mazariegos GV
    Curr Opin Organ Transplant; 2010 Feb; 15(1):28-34. PubMed ID: 19890211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation tolerance. A complex scenario awaiting clinical applicability.
    Sayegh MH; Perico N; Remuzzi G
    Contrib Nephrol; 2005; 146():95-104. PubMed ID: 15567924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflections on the unique tolerogenicity of bone marrow, the enigma of chimerism and clinical tolerance.
    Monaco AP
    Clin Transpl; 2013; ():157-66. PubMed ID: 25095504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance in clinical liver transplantation.
    Levitsky J; Feng S
    Hum Immunol; 2018 May; 79(5):283-287. PubMed ID: 29054397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.